Research News and Research

RSS

Health IT opportunities abound, some studies question value

"The rest of the world has embraced e-mail, online forms and iPhone apps, but health care still communicates in the centuries-old technology of paper," McClatchy/Tribune News reports. Now, technology companies are recognizing a business opportunity in that shortcoming. Moving to electronic medical records can be expensive - Kaiser Permanente spent $4 billion switching from paper to digital - meaning money in the bank for well-poised vendors.

26 Oct 2009

Tart cherry juice may help runners recover quickly and effectively from post-race pain

From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.

26 Oct 2009

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

ADA Technologies, Inc. (ADA) received a $189,886 grant from the National Institute of Mental Health to develop a home lithiummonitor for use by patients with bipolar disorder.

26 Oct 2009

CMSC analyses patient self-management in Multiple Sclerosis

The Consortium of Multiple Sclerosis Centers (CMSC) released a white paper, written by a panel chaired by CMSC member Robert T. Fraser, Ph.D., of the University of Washington Rehabilitation Research and Training Center in Seattle, Washington, analyzing patient self-management in Multiple Sclerosis (MS) to develop recommendations for best practices aimed at improving patients' lives.

26 Oct 2009

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Allegheny Technologies Incorporated announced that it has completed the purchase of the assets of Crucible Compaction Metals and Crucible Research for $40.95 million.

26 Oct 2009

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Rexahn Pharmaceuticals, Inc. announced today that it has completed its previously announced Registered Direct Offering of common stock and warrants. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NasdaqGM: RODM), acted as the exclusive placement agent for this transaction.

26 Oct 2009

Dysport, a new wrinkle fighter, available now in the United States

The story: Dysport(TM), a new wrinkle fighter, is now available in the United States. Dysport(TM) is a Botulinum-A enzyme like Botox Cosmetic. Dysport(TM) is positioned as the new arch-nemesis and first direct competitor of Botox Cosmetic in the United States.

26 Oct 2009

American Heart Association joins international organizations to fight the global threat of stroke

During this year's observance of "World Stroke Day," Thursday, October 29, the American Heart Association and its division, the American Stroke Association, will join international organizations with a unified message about the global threat of stroke.

26 Oct 2009

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.

26 Oct 2009

Winners of the EDCTP Award For Outstanding African Scientist

The European & Developing Countries Clinical Trials Partnership (EDCTP) has given its Awards for Outstanding African Scientist to Dr Alexis Nzila and Dr Dominique Pepper.

26 Oct 2009

Anti-viral drug development programs progress successfully, reports NanoViricides

NanoViricides, Inc. (the "Company"), reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in stock price and associated volatility.

26 Oct 2009

First Edition: October 26, 2009

Several Democratic senators voiced optimism on Sunday that Congress would pass a health care bill containing at least the germ of a government-run insurance program. Their expectations were grudgingly seconded by Senator John McCain, the Republican presidential candidate in 2008 (The New York Times).

26 Oct 2009

Appropriate diet lessens inflammation and muscular damage, leads to higher performance in competition sports

21 male skiers with an average age of 37 were studied and the results showed normal body weight as well as fat and muscle percentage and a predominantly athletic body build.

26 Oct 2009

Ingenuity Systems and Life Technologies develop new gene expression workflow for cell transcriptome analysis

Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced it has developed a new gene expression workflow with Life Technologies Corporation.

26 Oct 2009

Ceragenix Pharmaceuticals updates its cooperative research and development with MAST BioSurgery

Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the “Company”), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement”) with MAST BioSurgery Inc. (“MAST”) for the development of one or more new surgical products incorporating Ceragenix’s CeraShield™ antimicrobial technology.

26 Oct 2009

STAAR Surgical Company reports promising assessments from CAST

STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported that the Collamer Accommodating Study Team (CAST) formed by the company in late 2008 has provided very promising initial patient vision assessments from the first phase of the project.

26 Oct 2009

Rega Institute and CD3 to receive funds for new medication research for dengue treatment

The Laboratory for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre for Drug Design and Discovery" (CD3) at K.U.Leuven will receive a total of 2.8 million euro from the British Wellcome Trust. - They will apply these funds to the search for possible new medication for the treatment of infections related to the 'dengue fever virus'.

26 Oct 2009

Thomson Reuters: The U.S. healthcare system wastes an estimated amount of $700 billion annually

The U.S. healthcare system wastes between $600 billion and $850 billion annually, according to a white paper published today by Thomson Reuters.

26 Oct 2009

Younger women experience larger improvements after myocardial infarction than men

In recent years, women, particularly younger women, experienced larger improvements in hospital mortality after myocardial infarction (MI) than men, according to a study published in the Oct. 26, 2009 issue of Archives of Internal Medicine.

26 Oct 2009

Comparison study between pre and postoperative BNP measurements for predicting negative outcomes after CABG surgery

Results from a clinical study presented at the 2009 American Society of Anesthesiologists (ASA) Meeting suggest that elevated preoperative levels of the B-type natriuretic peptide (BNP) biomarker may predict hospital length of stay and mortality after primary coronary artery bypass graft surgery better than measurements of elevated postoperative BNP levels.

26 Oct 2009

Research News and Research

Health IT opportunities abound, some studies question value

Tart cherry juice may help runners recover quickly and effectively from post-race pain

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

CMSC analyses patient self-management in Multiple Sclerosis

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Dysport, a new wrinkle fighter, available now in the United States

American Heart Association joins international organizations to fight the global threat of stroke

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Winners of the EDCTP Award For Outstanding African Scientist

Anti-viral drug development programs progress successfully, reports NanoViricides

First Edition: October 26, 2009

Appropriate diet lessens inflammation and muscular damage, leads to higher performance in competition sports

Ingenuity Systems and Life Technologies develop new gene expression workflow for cell transcriptome analysis

Ceragenix Pharmaceuticals updates its cooperative research and development with MAST BioSurgery

STAAR Surgical Company reports promising assessments from CAST

Rega Institute and CD3 to receive funds for new medication research for dengue treatment

Thomson Reuters: The U.S. healthcare system wastes an estimated amount of $700 billion annually

Younger women experience larger improvements after myocardial infarction than men

Comparison study between pre and postoperative BNP measurements for predicting negative outcomes after CABG surgery

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms